These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32141702)

  • 1. Antibiotic tigecycline inhibits cell proliferation, migration and invasion via down-regulating CCNE2 in pancreatic ductal adenocarcinoma.
    Yang J; Dong Z; Ren A; Fu G; Zhang K; Li C; Wang X; Cui H
    J Cell Mol Med; 2020 Apr; 24(7):4245-4260. PubMed ID: 32141702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
    Liu G; Ji L; Ke M; Ou Z; Tang N; Li Y
    Biomed Pharmacother; 2018 Oct; 106():523-531. PubMed ID: 29990840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma.
    Okada Y; Takahashi N; Takayama T; Goel A
    Carcinogenesis; 2021 Apr; 42(4):546-556. PubMed ID: 33624791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539.
    Nai Y; Pan C; Hu X; Ma Y
    Cancer Med; 2020 Jan; 9(2):757-767. PubMed ID: 31789465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling.
    Tactacan CM; Phua YW; Liu L; Zhang L; Humphrey ES; Cowley M; Pinese M; Biankin AV; Daly RJ
    Mol Cancer; 2015 Jul; 14():139. PubMed ID: 26215634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells.
    Dai H; Shen K; Yang Y; Su X; Luo Y; Jiang Y; Shuai L; Zheng P; Chen Z; Bie P
    Cell Death Dis; 2019 Aug; 10(8):595. PubMed ID: 31395860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal Muscle-Derived Irisin Enhances Gemcitabine Sensitivity and Suppresses Migration Ability in Pancreatic Ductal Adenocarcinoma.
    Sugimoto T; Iwagami Y; Kobayashi S; Yamanaka C; Sasaki K; Yamada D; Tomimaru Y; Asaoka T; Noda T; Takahashi H; Shimizu J; Doki Y; Eguchi H
    Ann Surg Oncol; 2024 Jun; 31(6):3718-3736. PubMed ID: 38502294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner.
    Hu H; Dong Z; Tan P; Zhang Y; Liu L; Yang L; Liu Y; Cui H
    Oncotarget; 2016 Jan; 7(3):3171-85. PubMed ID: 26621850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tsoong induces apoptosis and inhibits proliferation, migration and invasion of pancreatic ductal adenocarcinoma cells.
    Luan YP; Li QF; Wu SG; Mao DC; Deng YY; Chen RW
    Mol Med Rep; 2018 Mar; 17(3):3527-3536. PubMed ID: 29286105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer.
    Takahashi K; Ota Y; Kogure T; Suzuki Y; Iwamoto H; Yamakita K; Kitano Y; Fujii S; Haneda M; Patel T; Ota T
    Cancer Sci; 2020 Jan; 111(1):98-111. PubMed ID: 31715081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.
    Momeny M; Alishahi Z; Eyvani H; Esmaeili F; Zaghal A; Ghaffari P; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Cell Oncol (Dordr); 2020 Feb; 43(1):81-93. PubMed ID: 31512195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-treatment with gemcitabine and nab-paclitaxel exerts additive effects on pancreatic cancer cell death.
    Passacantilli I; Panzeri V; Terracciano F; Delle Fave G; Sette C; Capurso G
    Oncol Rep; 2018 Apr; 39(4):1984-1990. PubMed ID: 29393478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage.
    El Hassouni B; Mantini G; Immordino B; Peters GJ; Giovannetti E
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31817270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling.
    Duan W; Qian W; Zhou C; Cao J; Qin T; Xiao Y; Cheng L; Li J; Chen K; Li X; Ma J; Ma Q
    Oncol Rep; 2018 Sep; 40(3):1495-1502. PubMed ID: 29956804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ProNGF siRNA inhibits cell proliferation and invasion of pancreatic cancer cells and promotes anoikis.
    Xu J; Song J; Yang X; Guo J; Wang T; Zhuo W
    Biomed Pharmacother; 2019 Mar; 111():1066-1073. PubMed ID: 30841420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The overexpression of long intergenic ncRNA00162 induced by RelA/p65 promotes growth of pancreatic ductal adenocarcinoma.
    Lu Y; Wu M; Fu J; Sun Y; Furukawa K; Ling J; Qin X; Chiao PJ
    Cell Prolif; 2020 May; 53(5):e12805. PubMed ID: 32364285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-24-3p Regulates Epithelial-Mesenchymal Transition and the Malignant Phenotype of Pancreatic Adenocarcinoma by Regulating ASF1B Expression.
    Huang W; Lin T; Huang L; Wu J; Hong J; Qiu F; Tian Y; Wang Y
    Biochem Genet; 2023 Apr; 61(2):742-761. PubMed ID: 36114946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.